HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lifang Cheng Selected Research

Integrins

1/2016Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
1/2016cRGDyK modified pH responsive nanoparticles for specific intracellular delivery of doxorubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lifang Cheng Research Topics

Disease

13Neoplasms (Cancer)
04/2023 - 12/2013
3Lung Neoplasms (Lung Cancer)
10/2021 - 01/2020
3Breast Neoplasms (Breast Cancer)
10/2021 - 12/2014
2Inflammation (Inflammations)
03/2024 - 11/2022
2Bullous Pemphigoid (Pemphigoid)
01/2023 - 01/2023
2Melanoma (Melanoma, Malignant)
10/2021 - 01/2017
2Carcinogenesis
01/2020 - 03/2017
1Ovarian Neoplasms (Ovarian Cancer)
04/2023
1Neoplasm Metastasis (Metastasis)
04/2023
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2023
1Psoriatic Arthritis
01/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021
1Heart Failure
01/2021
1Osteoarthritis
10/2017
1Colorectal Neoplasms (Colorectal Cancer)
03/2015

Drug/Important Bio-Agent (IBA)

4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 12/2014
3Dendrimers (Dendrons)IBA
10/2020 - 12/2015
3Folic Acid (Vitamin M)FDA LinkGeneric
12/2015 - 12/2013
2Immune Checkpoint InhibitorsIBA
01/2023 - 01/2022
2NanovaccinesIBA
10/2021 - 01/2017
2Poly(amidoamine)IBA
01/2020 - 12/2015
2IntegrinsIBA
01/2016 - 01/2016
2MicellesIBA
01/2016 - 12/2014
1GTP Phosphohydrolases (GTPases)IBA
03/2024
1Immunoglobulin A (IgA)IBA
01/2023
1AutoantibodiesIBA
01/2023
1Matrix Metalloproteinases (MMPs)IBA
01/2023
1Laminin (Merosin)IBA
01/2023
1Docosahexaenoic AcidsIBA
11/2022
1CytokinesIBA
11/2022
115-hydroxy-5,8,11,13,17-eicosapentaenoic acidIBA
11/2022
1Eicosapentaenoic AcidIBA
11/2022
1NanogelsIBA
01/2022
1secukinumabIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1AntigensIBA
10/2021
1Urea (Carbamide)FDA LinkGeneric
10/2021
1VaccinesIBA
10/2021
1Cancer VaccinesIBA
10/2021
1Gefitinib (Iressa)FDA Link
10/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1PAMAM-G4IBA
10/2020
1ClathrinIBA
01/2020
1Transferrin (beta 2 Transferrin)IBA
01/2020
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020
1methoxypolyethylene glycol succinimidylsuccinateIBA
01/2020
1PEG-PAMAMIBA
10/2017
1Fluorescein (Funduscein)FDA LinkGeneric
10/2017
1Long Noncoding RNAIBA
03/2017
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
01/2017
1CPG-oligonucleotideIBA
01/2017
1cyclic arginine-glycine-aspartic acid peptideIBA
01/2016
1cyclo(Arg-Gly-Asp-Tyr-Lys)IBA
01/2016
1PAMAM StarburstIBA
12/2015
1AcidsIBA
12/2015
1TOR Serine-Threonine KinasesIBA
03/2015
1polyhistidineIBA
12/2014
1Peptides (Polypeptides)IBA
12/2014
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2014
1Liposomes (Liposome)IBA
12/2014
1Hyaluronic Acid (Hyaluronan)IBA
12/2014
1polyethylene glycol 2000IBA
12/2014
1ChitosanIBA
12/2013
1DNA (Deoxyribonucleic Acid)IBA
12/2013
1Proteins (Proteins, Gene)FDA Link
12/2013

Therapy/Procedure

5Therapeutics
01/2022 - 11/2014
3Drug Therapy (Chemotherapy)
04/2023 - 01/2016
2Immunotherapy
01/2023 - 10/2021
1Highly Active Antiretroviral Therapy (HAART)
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022